Anesthesia Payer Contracting and the No Surprises Act IDR Process

by | Jan 21, 2026 | Financial Oversight

anesthesia payer contracting

In 2024, providers won 85 percent of IDR disputes, with median payment determinations running significantly above the qualifying payment amount. But winning a dispute and having a functioning contract are not the same thing. Here is how to use both.

Key Takeaways

  1. In 2024, providers won approximately 85 percent of IDR disputes, with median payment determinations well above the qualifying payment amount (QPA). Anesthesia disputes ran at roughly two times the QPA at median.
  2. The IDR process is a fallback, not a strategy. Groups that allow contracts to expire and rely on IDR for payment incur high administrative costs and cash flow disruption. The process is most valuable as leverage in a negotiation, not as a routine revenue channel.
  3. Commercial anesthesia contracts are typically expressed as a percentage of the Medicare fee schedule or as a custom unit conversion factor. Either way, knowing your Medicare equivalent rate by payer is the benchmark that makes the negotiation concrete.
  4. The No Surprises Act prohibits balance billing for most anesthesia services in hospital and ASC settings. Consent forms and advance notice practices that predate the Act may expose your group to complaint and enforcement action and should be reviewed.

Anesthesia groups occupy an unusual position in the payer contracting world. Unlike primary care or most surgical specialties, anesthesia is delivered in a facility setting where patients do not choose their anesthesia provider the way they choose a surgeon. The patient selects the hospital and the surgeon; the anesthesia group follows the exclusive contract. That dynamic has historically given payers leverage in negotiations: the anesthesia group cannot simply terminate a contract and send patients elsewhere, because it has no direct patient relationship to take anywhere. The No Surprises Act, effective January 2022, changed the stakes of that asymmetry without eliminating it.

Under the Act, most anesthesia services delivered in hospitals or ambulatory surgical centers are covered by the surprise billing prohibition. A patient with in-network hospital coverage cannot be billed beyond their in-network cost-sharing for anesthesia services, even if the anesthesia group is out-of-network with their insurer. The payer must pay the group directly, at a rate determined either by agreement or by the independent dispute resolution (IDR) process. In practice, this means that an anesthesia group that is out-of-network with a commercial payer is no longer simply forgoing those patients’ revenue – it is generating claims that must go through IDR or negotiation. That creates real leverage, but also real administrative cost.

What the IDR Data Actually Shows

The federal IDR process has generated a substantial body of outcome data since it launched in 2022. Georgetown’s Center on Health Insurance Reforms reported that in 2024, providers won approximately 85 percent of disputes, with median payment determinations rising through the year – reaching 459 percent of the qualifying payment amount (QPA) in the fourth quarter. Anesthesia-specific outcomes have been more modest: CMS data shows median payment determinations for anesthesia disputes running at roughly two times the QPA, which is meaningfully above the QPA but below the figures seen in emergency medicine. The implication is that IDR arbitrators, who are required to consider the QPA along with other factors, have generally found that anesthesia rates in competitive markets exceed the QPA – but not by the multiples seen in some other hospital-based specialties.

The American Society of Anesthesiologists, alongside emergency medicine and radiology groups, has pressed CMS to finalize the IDR Operations Final Rule – a rule that has been in development for years and would address inefficiencies in the process that have driven up administrative costs for both providers and payers. CMS has not yet finalized the rule as of mid-2026. Groups relying on IDR as a regular revenue channel should budget for the administrative cost of dispute initiation, the open-negotiation period, and the arbitration fee structure, all of which are non-trivial at scale.

Using IDR as Leverage, Not as a Billing Strategy

The most productive way to use the IDR framework is as a negotiating tool, not as a claims processing pipeline. The process works like this: a payer and a group have 30 business days from the initial payment to negotiate; if they cannot agree, either party can initiate IDR; the arbitrator selects either the payer’s offer or the provider’s offer, with no split-the-difference option. Knowing that arbitrators have consistently selected provider offers at rates above the QPA changes the negotiating dynamic. A payer that would previously refuse to move above QPA now has a reason to settle, because the alternative is an IDR outcome that may cost them significantly more.

Groups that use this leverage effectively do two things. First, they build a detailed rate comparison showing their current contracted rates as a percentage of the Medicare fee schedule equivalent, compared to published benchmark rates and to known IDR award levels in their region. Second, they initiate IDR selectively and promptly on claims where the gap is largest, creating a track record that documents what the market will support. That track record is then referenced in the next contract renegotiation as evidence of prevailing market rates. The IDR process, used this way, is a market rate discovery tool – expensive to run at volume, but valuable for establishing the data that makes the next contract negotiation concrete.

IDR arbitrators select one offer or the other. Groups that understand this submit their offer at what the market will support, not at what they hope to get. The data to calibrate that offer exists in public IDR outcome reports.

Structuring Commercial Contracts

Commercial anesthesia contracts are typically expressed in one of two ways: as a percentage of the CMS fee schedule (for example, 120 percent of Medicare), or as a custom conversion factor applied to ASA unit values. Either way, the comparison point is the Medicare rate. Building a payer-by-payer rate schedule that translates each contract into a Medicare equivalent percentage is the foundational step in any contracting analysis, because it allows an apples-to-apples comparison across payers and against market benchmarks.

  • Conversion factor parity. If your commercial contract expresses rates as a conversion factor per ASA unit, convert it to a Medicare equivalent by dividing the commercial factor by the current Medicare factor ($20.4976 for 2026). A commercial conversion factor of $24.00 equals approximately 117 percent of Medicare.
  • Escalation clauses. A contract without an annual escalation clause loses value every year against inflation. A fixed dollar conversion factor from 2019 is worth meaningfully less in 2026 terms. Negotiate an index – CPI-U or a fixed percentage – and a floor below which rates cannot be reset at renewal.
  • Case mix adjustments. If your group covers a high-acuity service line (cardiac, neurosurgery, pediatrics) that generates higher base units per case, the effective yield of a flat conversion factor is higher than for a general surgery group. This works both ways: a payer negotiating a flat factor for a group with rising acuity is getting a better deal over time. Build the case mix data into the conversation.
  • Claims editing and bundling policies. Some payers apply edits that bundle qualifying circumstance units, cap time units, or deny modifiers for specific procedure codes. These policies reduce the effective rate below the stated conversion factor. Review the remittance data for edit patterns before you accept a contract rate as final.

No Surprises Act Compliance Obligations

The Act imposes obligations beyond the billing prohibition. Good-faith cost estimates must be provided to uninsured and self-pay patients. The consent forms that some anesthesia groups used historically to obtain advance patient agreement to out-of-network billing are no longer valid as a basis for balance billing in most hospital and ASC settings. If your group has consent language in its patient intake documents that predates January 2022, or that purports to authorize charges above the patient’s in-network cost-sharing, that language should be reviewed by counsel. Patient complaints about balance billing are reported to the HHS No Surprises Help Desk, which routes them to the relevant state insurance department or federal enforcement authority. The enforcement risk is real and the complaint pathway is simple for patients to use.

From the Field

A nine-physician anesthesia group in the Southwest was out-of-network with one regional commercial payer and had been processing those claims through IDR on a case-by-case basis for 18 months. The administrative cost of the IDR process – tracking open negotiation periods, paying dispute initiation fees, and managing arbitration filings – had become significant, and the group’s administrator was spending roughly a day per week on IDR management. Our engagement built a rate reconciliation showing the group’s IDR award history with that payer against the payer’s proposed in-network conversion factor, translating both into Medicare equivalent percentages. The analysis showed the payer’s in-network offer was at 108 percent of Medicare while the group’s IDR awards had averaged 141 percent. Presented with that comparison in a renegotiation meeting, along with the group’s intent to continue selective IDR filings, the payer moved to 127 percent – not the full IDR average, but well above the in-network offer and a level at which the group’s administrator could return her time to other work. The fractional CFO engagement modeled the contract, attended the negotiation session, and built the reporting template the group’s billing team now uses to track effective rates by payer on a rolling basis.

Consulting or Fractional for Contracting

A contracting analysis – the rate reconciliation, the payer grid, the IDR benchmark comparison – is a consulting deliverable. A skilled healthcare attorney or consultant can produce it and hand it to your managing partner or administrator to take into the negotiation. If your group has someone with the bandwidth and the negotiating experience to use it, that may be the right scope, and it is often the more cost-effective approach.

What we more commonly see is a group whose managing partner is also a full-time clinician and whose administrator handles billing, credentialing, and scheduling simultaneously. In that structure, the contracting analysis does not get used effectively because nobody has the time to manage negotiations through multiple counter-proposals, track IDR filings against the negotiating timeline, and monitor contract language through redlines. A fractional CFO engagement covers the analysis and the execution: attending the negotiation, managing the IDR tracking, reviewing the final language before signature. Whether that cost is justified depends on the rate gap and how many years the contract will run at whatever rate you agree to.

Sources

  1. Georgetown Center on Health Insurance Reforms, Independent Dispute Resolution Process 2024 Data: High Volume, More Provider Wins — https://chir.georgetown.edu/independent-dispute-resolution-process-2024-data-high-volume-more-provider-wins/
  2. CMS, Independent Dispute Resolution Process Reports (No Surprises Act) — https://www.cms.gov/nosurprises/policies-and-resources/reports
  3. American Society of Anesthesiologists, Washington Alert: ASA Urges Swift Release of Final IDR Operations Rule (October 2025) — https://www.asahq.org/advocacy-and-asapac/fda-and-washington-alerts/washington-alerts/2025/10/asa-urges-swift-release-of-final-idr-operations-rule-to-stabilize-no-surprises-act-implementation
  4. CMS, CY 2026 Physician Fee Schedule Final Rule – Anesthesia Conversion Factor ($20.4976) — https://www.cms.gov/medicare/payment/fee-schedules/physician/anesthesiologists-center

More in the Anesthesiology Series

See the full Anesthesiology practice management page →